Vanda Pharmaceuticals Inc. v. Inventia Healthcare Limited
1:15-cv-00362
Overview
Parties
Defendant
Inventia Healthcare Limited NPE (University / Research)
Represented By
6 Attorneys ListedMorris James LLP
500 Delaware Avenue, Suite 1500
ADDRESS EXPIRED / UNKNOWN
ADDRESS EXPIRED / UNKNOWN, (302) 888-6800
Inventia Healthcare PVT Ltd. Operating Company
Represented By
6 Attorneys ListedADDRESS EXPIRED / UNKNOWN
ADDRESS EXPIRED / UNKNOWN, (302) 888-6800
Plaintiff
Vanda Pharmaceuticals Inc. Operating Company
Represented By
9 Attorneys ListedMcDermott Will & Emery LLP
4th floor, The Brandywine Building
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 5 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🌐 PCT International (WIPO) | PCT World Application | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → |
Roxane Laboratories, Inc. et al. v. Vanda Pharmaceuticals Inc.
Patents Involved
There are 2 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US8586610
Methods for the administration of iloperidone
|
Filed: 2005-09-30
Issued: 2013-11-19
|
Active (1.0 yrs remaining)
+763d PTA
Expires: 2027-11-02
|
|
|
US9138432
Methods for the administration of iloperidone
|
Filed: 2014-01-08
Issued: 2015-09-22
|
Active (7.1 yrs remaining)
Expires: 2034-01-08
|
Patent Enforceability & Injunction Risk Assessment
Active Threat — Patent is within enforceable statutory term; injunctive relief viable.
High PTA (+763 days) / In re Cellect scrutiny applies.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
40
Dispositive
8
Granted
0
Denied
1
Pending / Review
27
Motions by Category
Key Dispositive Motions & Rulings